These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Drug management of Parkinson's disease. Kishore A; Snow BJ Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697 [TBL] [Abstract][Full Text] [Related]
10. Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs. Davis LE; Adair JC Mov Disord; 1999 May; 14(3):520-2. PubMed ID: 10348484 [No Abstract] [Full Text] [Related]
11. [Crises in the course of Parkinson's disease]. Danielczyk W Wien Med Wochenschr; 1980 Feb; 130(4):149-51. PubMed ID: 7376682 [No Abstract] [Full Text] [Related]
17. L-dopa responsive parkinsonism secondary to a subdural haematoma. Ellul MA; Cross J; Barker RA J Clin Neurosci; 2013 Jul; 20(7):1022-4. PubMed ID: 23618681 [TBL] [Abstract][Full Text] [Related]
18. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome]. Kamianov IM; Kupisk AG; Katsen IZ Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581 [No Abstract] [Full Text] [Related]
19. Hemiparkinsonism. A human model for studying dopaminergic supersensitivity. Trabucchi M; Albizzati MG; Frattola L; Scarlato G Arch Neurol; 1979 Apr; 36(4):246-8. PubMed ID: 426672 [TBL] [Abstract][Full Text] [Related]